CLINICAL_TRIALS
trial_result
· 2018-08-21
Clinical Trial Update: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) [Phase 3]
Summary
Phase 3 clinical trial update for treatments in central retinal vein occlusion (SCORE2) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: The Emmes Company, LLC | Conditions: Central Retinal Vein Occlusion | Phase 3 | Status: COMPLETED | Results posted: 2018-08-21